Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1744* | 2021 |
A survey on security and privacy of 5G technologies: Potential solutions, recent advancements, and future directions R Khan, P Kumar, DNK Jayakody, M Liyanage IEEE Communications Surveys & Tutorials 22 (1), 196-248, 2019 | 492 | 2019 |
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 439* | 2021 |
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 317 | 2021 |
Role of salivary biomarkers in oral cancer detection Z Khurshid, MS Zafar, RS Khan, S Najeeb, PD Slowey, IU Rehman Advances in clinical chemistry 86, 23-70, 2018 | 263 | 2018 |
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 218 | 2022 |
Transformational leadership and organizational innovation: Moderated by organizational size R Khan, AU Rehman, A Fatima African Journal of Business Management 3 (11), 678, 2009 | 204 | 2009 |
Salivary IL-8, IL-6 and TNF-α as potential diagnostic biomarkers for oral cancer HA Sahibzada, Z Khurshid, R Sannam Khan, M Naseem, ... Diagnostics 7 (2), 21, 2017 | 165 | 2017 |
Advancing Point-of-Care (PoC) Testing Using Human Saliva as Liquid Biopsy RS Khan, Z Khurshid, F Yahya Ibrahim Asiri Diagnostics 7 (3), 39, 2017 | 127 | 2017 |
Investing in medication adherence improves health outcomes and health system efficiency: adherence to medicines for diabetes, hypertension, and hyperlipidaemia R Khan, K Socha-Dietrich OECD, 2018 | 116 | 2018 |
Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies DS Hong, SM Sebti, RA Newman, MA Blaskovich, L Ye, RF Gagel, ... Clinical Cancer Research 15 (22), 7061-7068, 2009 | 97 | 2009 |
Diameter protocol and SH interface support for SIP server architecture AR Langen, D Connelly, RN Khan, I Cosmadopoulos, J Wilkiewicz US Patent 8,219,697, 2012 | 89 | 2012 |
The prevalence of silent kidney stones: an ultrasonographic screening study B Niels-Peter, F Abbas, R Khan, JJ Talati, M Afzal, I Rizvi Journal of the Pakistan Medical Association 53 (1), 24, 2003 | 89 | 2003 |
The therapeutic role of Cannabidiol in mental health: a systematic review R Khan, S Naveed, N Mian, A Fida, MA Raafey, KK Aedma Journal of cannabis research 2, 1-21, 2020 | 84 | 2020 |
First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors DS Hong, H Henary, GS Falchook, A Naing, S Fu, S Moulder, JJ Wheler, ... Investigational new drugs 32, 1204-1212, 2014 | 76 | 2014 |
Role of salivary biomarkers in detection of cardiovascular diseases (CVD) S Abdul Rehman, Z Khurshid, F Hussain Niazi, M Naseem, H Al Waddani, ... Proteomes 5 (3), 21, 2017 | 75 | 2017 |
Neighbourhood safety and area deprivation modify the associations between parkland and psychological distress in Sydney, Australia S Chong, E Lobb, R Khan, H Abu-Rayya, R Byun, B Jalaludin BMC public health 13, 1-8, 2013 | 66 | 2013 |
Significance and diagnostic role of antimicrobial cathelicidins (LL-37) peptides in oral health Z Khurshid, M Naseem, F Yahya I. Asiri, M Mali, R Sannam Khan, ... Biomolecules 7 (4), 80, 2017 | 55 | 2017 |
Advances of salivary proteomics in oral squamous cell carcinoma (OSCC) detection: an update R Sannam Khan, Z Khurshid, S Akhbar, S Faraz Moin Proteomes 4 (4), 41, 2016 | 55 | 2016 |
Human oral defensins antimicrobial peptides: a future promising antimicrobial drug Z Khurshid, MS Zafar, M Naseem, RS Khan, S Najeeb Current pharmaceutical design 24 (10), 1130-1137, 2018 | 53 | 2018 |